D.S. Research & Hospital Institute Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 06-07-2024
- Paid Up Capital ₹ 0.10 M
as on 06-07-2024
- Company Age 20 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 35.00%
(FY 2022)
- Profit 90.63%
(FY 2022)
- Ebitda 15.10%
(FY 2022)
- Net Worth -9.75%
(FY 2022)
- Total Assets 4.60%
(FY 2022)
About D.S. Research & Hospital Institute
The Corporate was formerly known as D. S. Dispensing & Research Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pankaj Trivedi and Kallol Biswas serve as directors at the Company.
- CIN/LLPIN
U24239WB2004PTC097774
- Company No.
097774
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Feb 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at D.S. Research & Hospital Institute?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pankaj Trivedi  | Director | 30-Dec-2013 | Current |
| Kallol Biswas | Director | 30-May-2015 | Current |
Financial Performance and Corporate Structure Insights of D.S. Research & Hospital Institute.
D.S. Research & Hospital Institute Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 35% increase. The company also saw a substantial improvement in profitability, with a 90.63% increase in profit. The company's net worth dipped by a decrease of 9.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of D.S. Research & Hospital Institute?
In 2019, D.S. Research & Hospital Institute had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
D. S. Healthcare Private LimitedActive 17 years 7 monthsPankaj Trivedi and Kallol Biswas are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at D.S. Research & Hospital Institute?
Unlock and access historical data on people associated with D.S. Research & Hospital Institute, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of D.S. Research & Hospital Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped D.S. Research & Hospital Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
